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Improvement in the laboratory diagnosis of thyroid status in severely ill patients. Clin ChimActa 118,209-218(1982 498-504 (1983) . 9. Burr We critically examined a current manufacturer's recommendation concerning reconstitution and stabilization of their lyophilized control material, and we compare qualitycontrol data obtained with our stabilized acid phosphatase material with those of other laboratories sharing the same lots of quality control material and using the Dii Pont aca.
Materials and Methods
Stabilized acid phosphatase control materials were prepared as follows. Initially, 41 stabilizer tablets (Sigma Chemical Co, St. Louis, MO 63178) for prostatic acid phosphatase were dissolved in 41 mL of de-ionized water, each tablet containing 4 mg of citric acid plus filler. After the stabilizer tablets dissolved completely, we added 10 mL of this solution to each of two 10-mL vials of Ortho Normal unassayed serum control (Ortho Diagnostic Systems, Raritan, NJ 08869) and two 10-mL vials of Ortho Abnormal unassayed serum control. All vials were rocked on a mixer for 10 mm, the vials being vented at 4 and 8 mm. Each pair of the two 10-mL vials of control material was pooled, and 1-mL aliquots were stored frozen (-4 #{176}C) were tested for acid phosphatase activity with the Dii Pont aca, then retested every 2 h for a total of 12 h; vials were kept at room temperature between assays. The bovine Ortho control materials were similarly tested every 2 h for 8 h.
We measured the pH of each control vial (human and bovine) after the four treatments described above (pH MM ResearchpH meter; The London Co., Cleveland, OH 44145), and monitored the pH of a solution of citric acid stabilizer tablets in 5 mL of water, with the probes in close proximity to the five dissolving tablets, during the interval required for the tablets to dissolve completely (5 mm). To test the lability of the acid phosphatase to changes in pH, we reconstituted vials of the Ortho human lyophilized control material with HC1 at pH = 1,2,3,4, and Sand then assayed each vial for acid phosphatase activity. Figure 1 shows the relative stability of acid phosphatase in the human and bovine control materials when reconstituted by the four methods described above. with the thymolpthalein acid phosphatase method, we then adjusted the pH of this control to 4.4 (similar to that of the citric acid-stabilized control with 1 mollL NaOH) and retested for acid phosphatase, still with negative results. The activity of the control material reconstituted with pH 2.0 HC1 (final pH 6.92) was 10.60 U/L, which increased to 11.1 U/L after 1 h at room temperature. This result is close to the 11.35 U/L obtained with direct citric acid reconstitution described above. Reconstitution of the same control material with HC1 solutions with pHs of 3, 4, and 5 gave acid phosphatase activities of 4.58 (0.93), 3.67 (0.07), and 3.94(0.37) UIL, respectively (values in parentheses are the activities found after 1 h of storage at room temperature).
The final pHs of the contents of these latter three vials ranged from 8.44 to 8.52-near the pH of 8.50 obtained by reconstituting a vial with de-iomzed water. Table 1 lists quality-control data for one month (18 assays) obtained on our human acid phosphatase controls prepared by direct reconstitution with citric acid, together with data from 14 other laboratories that were all using the same lot number of control materials and the Du Pont aca. Figure 1 illustrates that direct stabilization of lyophilized human controls with citric acid results in a significantly higher acid phosphatase activity than do the three other methods of control preparation.
Their collective mean value for the

Discussion
Because even the directly stabilized material described above is unstable, aliquoting and freezing is essential for an ongoing quality-control procedure involving human-serum-based controls. The bovine control material is more stable than the human lyophilized control (see Figure 2) ; again, the directly stabilized material gave the highest acid phosphatase activity, 8.14 UI L. Unlike the lyophilized control material of human origin the acid phosphatase activity of the bovine control, once reconstituted and stabilized, did not change appreciably during the 8-h testing period, although kept at room temperature.
Means and standard deviations listed in Table 1 for the laboratories using the identical lots of Ortho Normal and Abnormal human lyophilized control material for acid phosphatase together with the same equipment and reagents for testing were generally much lower than our means, indicating appreciable pre-testing losses of activity. The control manufacturer recommends adding the citric acid tablet to freshly reconstituted human control as a means of stabilizing the acid phosphatase activity (4) . Moreover, the control manufacturer suggests a "target" assay value of 7.2 U/L (lot no. 025X01) for the Du Pont aca group, with a target range of 5.1 to 9.3 U/L considered acceptable for controls in the assay (4) . This target value is 37% below our assay value of 11.35 UIL on this lot, obtained on using direct citric acid reconstitution.
Also, the manufacturer of the stabilizer tablet claims on the tablet vial that the tablet will "generally retain the serum's full prostatic acid phosphatase activity for several days at room temperature" when one tablet is added for each milliliter of serum. Using this recommended Our pH studies indicate that essentially all acid phosphatase activity is lost when the human lyophilized control is reconstituted with 0.1 mollL HC1, even though the final pH of the reconstituted control is buffered to a pH of 2.6. The measured pH of the dissolving stabilizer tablets approaches a pH of 2.0, and we reasoned that at this pH the acid phosphatase in the immediate vicinity of the dissolving citric acid tablet could be denatured.
However, when the human-source lyophilized control was reconstituted with a pH 2 HC1 solution, almost no acid phosphatase activity was lost, the value being 97% of that observed with direct citric acid reconstitution.
Evidently there is essentially no denaturation of acid phosphatase at the pH generated by the dissolving citric acid tablets. Thus we attribute the lower acid phosphatase results obtained for the human-source control material, when prepared by the indirect citric acid reconstitution and subsequent tablet addition methods, to activity losses related to inadequate acid stabilization during the reconstitution process. Estimates of imprecision (coefficients of variation) for both Normal and Abnormal controls for the laboratories CLIN. CHEM. 29/12, 2096 CHEM. 29/12, -2099 CHEM. 29/12, (1983 listed in Table 1 are as high as 70.4% for the Normal control and 34.5% for the Abnormal. As shown in Table 2 , the mean, standard deviation, and CV data collected and compared on a between-month basis showed that the stabilized lyophilized control material of human origin was satisfactory for controlling this assay in the aca for an extended period.
We conclude that lyophilized control material of human origin can be validly used in quality control of acid phosphatase assay after adequate stabilization by direct reconstitution with citric acid, with aliquots being stored frozen.
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